Effect of Manual Lymphatic Drainage on Breast Cancer-Related Postmastectomy Lymphedema A Meta-analysis of Randomized Controlled Trials

BackgroundManual lymphatic drainage (MLD) is widely used in the treatment of breast cancer-related postmastectomy lymphedema (BCRL). However, the therapeutic benefit of MLD on BCRL remains controversial.ObjectiveThe aim of this study was to analyze the efficacy of MLD for BCRL.MethodFour electronic databases were systematically searched for trials comparing MLD and no MLD treatment as options for BCRL. Comparative treatment results included reduction of upper extremity limb volume with subgroup analysis by the number and duration of treatments.ResultsA total of 457 patients were included in the analysis. There was no significant difference in the amount of upper extremity edema between the MLD treatment and control or no MLD groups (P = .11). However, when the treatment course was >= 20 sessions, there was a significant reduction in the upper extremity volume (P = .03). There was also a significant reduction in the upper extremity volume when treatment duration was >2 weeks (P = .03).ConclusionManual lymphatic drainage treatment statistically did not reduce the upper extremity limb volume of BCRL, but upper extremity volume was reduced at statistically significant levels when treatment number were >= 20 sessions or the duration of treatment was >2 weeks.Implication for PracticeReduction in upper limb volume is dependent on the number and duration of treatments. When treatment number were >= 20 sessions, or the duration of treatment was >2 weeks, reduction of upper limb volume was statistically achieved. Manual lymphatic drainage treatment can be clinically recommended to treat BCRL according to these parameters.

Automated summary

The efficacy of manual lymphatic drainage (MLD) for breast cancer-related postmastectomy lymphedema (BCRL) was analyzed in this study. The results showed that there was no significant difference in upper extremity edema between the MLD treatment and control groups. However, significant reductions in upper extremity volume were observed when the treatment course was >= 20 sessions or the duration of treatment was >2 weeks.